201920182017201620152014 May 19, 2014 Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer April 09, 2014 Spero Formed to Develop First-in-Class Therapeutics for Drug-Resistant Bacterial Infections Pagination First page First Previous page Previous … Page 5 Page 6 Page 7 Current page 8
